BOLD
Audentes Therapeutics, Inc
BOLD
BOLD
Delisted
BOLD was delisted on the 14th of January, 2020.
149 hedge funds and large institutions have $1.25B invested in Audentes Therapeutics, Inc in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 64 increasing their positions, 34 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
49% less call options, than puts
Call options by funds: $1.1M | Put options by funds: $2.15M
63% less funds holding in top 10
Funds holding in top 10: 8 → 3 (-5)
Holders
149
Holding in Top 10
3
Calls
$1.1M
Puts
$2.15M
Top Buyers
| 1 | +$17.9M | |
| 2 | +$15.8M | |
| 3 | +$10.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.72M |
| 5 |
Millennium Management
New York
|
+$7.17M |
Top Sellers
| 1 | -$25.6M | |
| 2 | -$19.8M | |
| 3 | -$9.04M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.52M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$6.99M |